IS7992A - Dýralaus frumuræktunar aðferð - Google Patents

Dýralaus frumuræktunar aðferð

Info

Publication number: IS7992A
Authority: IS; Iceland
Prior art keywords: cell culture; culture method; wild cell; wild; culture
Prior art date: 2003-03-03

Application number

IS7992A

Other languages

English (en)

Inventor

Ghislaine Louise Aerts Brigitte

Jules Maurice Ghislain Yves

Jane Gonze Marie-Monique

Solange Lucie Knott Isabelle

Maggetto Carine

Original Assignee

Glaxosmithkline Biologicals S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-03

Filing date

2005-08-18

Publication date

2005-08-18

2005-08-18 Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.

2005-08-18 Publication of IS7992A publication Critical patent/IS7992A/is

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Cell Biology (AREA)
Molecular Biology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IS7992A 2003-03-03 2005-08-18 Dýralaus frumuræktunar aðferð IS7992A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0304799.0A GB0304799D0 (en)	2003-03-03	2003-03-03	Novel method
PCT/EP2004/002067 WO2004078955A1 (en)	2003-03-03	2004-03-01	Animal-free cell culture method

Publications (1)

Publication Number	Publication Date
IS7992A true IS7992A (is)	2005-08-18

Family

ID=9953995

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7992A IS7992A (is)	2003-03-03	2005-08-18	Dýralaus frumuræktunar aðferð

Country Status (17)

Country	Link
US (1)	US8034617B2 (is)
EP (3)	EP2192175A1 (is)
JP (2)	JP4787739B2 (is)
KR (1)	KR101242090B1 (is)
CN (2)	CN1756837B (is)
AU (1)	AU2004217807B2 (is)
BR (1)	BRPI0407636A (is)
CA (1)	CA2517327A1 (is)
CO (1)	CO5601047A2 (is)
GB (1)	GB0304799D0 (is)
IS (1)	IS7992A (is)
MA (1)	MA27631A1 (is)
MX (1)	MXPA05009096A (is)
NO (1)	NO20054124L (is)
NZ (1)	NZ541908A (is)
RU (1)	RU2369634C2 (is)
WO (1)	WO2004078955A1 (is)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7824711B2 (en)	2003-12-11	2010-11-02	Isto Technologies, Inc.	Particulate cartilage system
WO2005103235A1 (ja) *	2004-04-19	2005-11-03	Denka Seiken Co., Ltd.	ウイルスの生産方法
JP2008518597A (ja) *	2004-10-29	2008-06-05	セントカー・インコーポレーテツド	化学的規定培地組成物
CA2601006C (en) *	2005-03-10	2012-10-23	Kyoritsu Seiyaku Corporation	Cell strain capable of being cultured without ingredients derived from animals, method of producing the same, method of producing virus using the same, and method of producing vaccine
JP2008541746A (ja) *	2005-06-03	2008-11-27	ビオヴィトルム・アクチボラゲット（プブリクト）	新規プロセス
EP1916964A4 (en)	2005-08-26	2015-11-04	Zimmer Inc	IMPLANTS AND METHODS FOR THE REPAIR, REPLACEMENT AND TREATMENT OF JOINT DISEASES
EP1764117A1 (en)	2005-09-20	2007-03-21	Zimmer GmbH	Implant for the repair of a cartilage defect and method for manufacturing the implant
US8163549B2 (en)	2006-12-20	2012-04-24	Zimmer Orthobiologics, Inc.	Method of obtaining viable small tissue particles and use for tissue repair
AU2008240191B2 (en)	2007-04-12	2013-09-19	Zimmer, Inc.	Compositions and methods for tissue repair
FI20075417A0 (fi) *	2007-06-05	2007-06-05	Marjo-Riitta Suuronen	Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
JP5431361B2 (ja)	2008-01-09	2014-03-05	セルカゲーエムベーハー	改善された培養培地添加物及びそれを用いる方法
SG173194A1 (en)	2009-02-17	2011-09-29	Glaxosmithkline Biolog Sa	Inactivated dengue virus vaccine with aluminium-free adjuvant
ES2533074T3 (es)	2010-04-26	2015-04-07	Novartis Ag	Medio de cultivo celular mejorado
CN101831415B (zh) *	2010-05-12	2012-05-30	江苏博立生物制品有限公司	一种提高糖化酶发酵水平的方法
CA2828110C (en) *	2011-02-28	2020-03-31	President And Fellows Of Harvard College	Cell culture system
CA2857930A1 (en)	2011-12-08	2013-06-13	Yeda Research And Development Co, Ltd.	Mammalian fetal pulmonary cells and therapeutic use of same
US9493744B2 (en) *	2012-06-20	2016-11-15	Genentech, Inc.	Methods for viral inactivation and other adventitious agents
US20130281355A1 (en) *	2012-04-24	2013-10-24	Genentech, Inc.	Cell culture compositions and methods for polypeptide production
JP6041199B2 (ja) *	2012-09-14	2016-12-07	国立大学法人大阪大学	三次元細胞培養体の製造方法
US20140178343A1 (en)	2012-12-21	2014-06-26	Jian Q. Yao	Supports and methods for promoting integration of cartilage tissue explants
WO2016203477A1 (en)	2015-06-18	2016-12-22	Yeda Research And Development Co. Ltd.	Conditioning protocols and use of same for tissue regeneration
US10004795B2 (en) *	2015-09-08	2018-06-26	Fundacao Butantan	Process for preparing an attenuated tetravalent dengue vaccine
BE1024160B9 (fr)	2015-12-22	2017-12-06	Glaxosmithkline Biologicals Sa	Formulation immunogène
CN105567628B (zh) *	2016-01-30	2019-07-12	令世鑫	一种全悬浮培养mdck细胞的低血清培养基
CN105779376B (zh) *	2016-03-24	2019-08-30	友康恒业生物科技（北京）有限公司	一种流感病毒分离无血清培养基及其用途和制备
CN105695393B (zh) *	2016-03-24	2019-09-10	友康恒业生物科技（北京）有限公司	一种mdck细胞无血清培养基及其用途和制备
KR101925079B1 (ko) *	2017-05-24	2018-12-04	가천대학교 산학협력단	Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법
CN107432931B (zh) *	2017-08-03	2018-04-13	长春祈健生物制品有限公司	一种微载体培养水痘病毒制备疫苗的方法
CN113227354A (zh) *	2019-01-17	2021-08-06	勃林格殷格翰动物保健美国公司	用于禽类疫苗生产的无血清培养基及其用途
IL322673A (en)	2019-12-31	2025-10-01	Air Protein Inc	High-protein food compositions
CN115244171A (zh) *	2020-01-24	2022-10-25	空气蛋白公司	微生物来源的蛋白质水解物以及其制备方法和用途
CN113373107B (zh) *	2021-01-29	2022-12-30	上海生物制品研究所有限责任公司	一种大规模制备传代鸡胚细胞生产病毒的方法
WO2024039216A1 (ko) *	2022-08-19	2024-02-22	셀미트주식회사	동물세포 또는 동물 세포주의 배양방법
CN115627255B (zh) *	2022-12-01	2023-04-07	天信和(苏州)生物科技有限公司	一种采用低血清培养基培养人二倍体细胞的方法
CN119979445B (zh) *	2025-04-10	2025-09-09	四川大学	一种培养基、口腔黏膜上皮细胞模型，及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL94611A (en) *	1989-06-05	1994-12-29	Organogenesis Inc	Medium for cell cultures containing insulin or growth factor similar to insulin, transferrin or iron ion, triiodothyronine or thyroxine and method of use
GB9022545D0 (en)	1990-10-17	1990-11-28	Wellcome Found	Culture medium
DE4115722A1 (de)	1991-05-14	1992-11-19	Boehringer Mannheim Gmbh	Serumfreies medium zur kultivierung von saeugerzellen
RU2057176C1 (ru) *	1992-05-20	1996-03-27	Институт генетики АН Республики Молдова	Питательная среда для культивирования клеток человека и животных
DZ1706A1 (fr) *	1992-08-07	2002-02-17	Merck & Co Inc	Vaccin contre le virus de l'hepatite a.
ES2164074T3 (es)	1992-09-18	2002-02-16	Smithkline Beecham Biolog	Vacunas de virus de la hepatitis a.
CN1088984A (zh) *	1993-11-11	1994-07-06	江西省医学科学研究所	一种用于造血祖细胞培养的无血清培养基
HRP950097A2 (en)	1994-03-08	1997-06-30	Merck & Co Inc	Hepatitis a virus culture process
ES2323490T3 (es)	1994-11-10	2009-07-17	Baxter Healthcare Sa	Procedimiento de produccion de agentes biologicos en un medio de cultivo sin proteinas.
WO1998000521A1 (fr) *	1996-06-28	1998-01-08	The Green Cross Corporation	Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives
AU3813597A (en) *	1996-07-26	1998-02-20	University Of Manitoba	Serum-free medium for growth of anchorage-dependant mammalian cells
AU4751697A (en) *	1996-10-10	1998-05-05	Douglas Danner	Animal cell culture media comprising plant-derived nutrients
AU7984498A (en) *	1997-06-25	1999-01-04	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Serum-free cell growth medium
US6656719B1 (en) *	1997-10-27	2003-12-02	Merck & Co., Inc.	Serum-free, low-protein media for rotavirus vaccine production
FR2775983B1 (fr)	1998-03-13	2000-11-10	Pasteur Merieux Serums Vacc	Milieu et procede de propagation et de multiplication virales
WO1999057246A1 (en) *	1998-05-01	1999-11-11	Life Technologies, Inc.	Animal cell culture media comprising non-animal or plant-derived nutrients
US6406909B1 (en) *	1998-07-10	2002-06-18	Chugai Seiyaku Kabushiki Kaisha	Serum-free medium for culturing animal cells
US6623959B2 (en) *	2001-06-13	2003-09-23	Ethicon, Inc.	Devices and methods for cell harvesting

2003
- 2003-03-03 GB GBGB0304799.0A patent/GB0304799D0/en not_active Ceased
2004
- 2004-03-01 EP EP10151351A patent/EP2192175A1/en not_active Ceased
- 2004-03-01 KR KR1020057016385A patent/KR101242090B1/ko not_active Expired - Fee Related
- 2004-03-01 MX MXPA05009096A patent/MXPA05009096A/es active IP Right Grant
- 2004-03-01 WO PCT/EP2004/002067 patent/WO2004078955A1/en not_active Ceased
- 2004-03-01 NZ NZ541908A patent/NZ541908A/en unknown
- 2004-03-01 CN CN2004800058488A patent/CN1756837B/zh not_active Expired - Fee Related
- 2004-03-01 EP EP04715891A patent/EP1599580A1/en not_active Ceased
- 2004-03-01 JP JP2006504501A patent/JP4787739B2/ja not_active Expired - Fee Related
- 2004-03-01 AU AU2004217807A patent/AU2004217807B2/en not_active Ceased
- 2004-03-01 RU RU2005125606/13A patent/RU2369634C2/ru not_active IP Right Cessation
- 2004-03-01 CN CNA2007101866779A patent/CN101200705A/zh active Pending
- 2004-03-01 CA CA002517327A patent/CA2517327A1/en not_active Abandoned
- 2004-03-01 BR BRPI0407636-2A patent/BRPI0407636A/pt not_active IP Right Cessation
- 2004-03-01 EP EP10151350A patent/EP2186885A1/en not_active Withdrawn
- 2004-03-01 US US10/547,804 patent/US8034617B2/en not_active Expired - Fee Related
2005
- 2005-08-18 IS IS7992A patent/IS7992A/is unknown
- 2005-08-31 CO CO05087280A patent/CO5601047A2/es not_active Application Discontinuation
- 2005-09-05 NO NO20054124A patent/NO20054124L/no not_active Application Discontinuation
- 2005-09-09 MA MA28488A patent/MA27631A1/fr unknown
2010
- 2010-07-12 JP JP2010157682A patent/JP2010273683A/ja active Pending

Also Published As

Publication number	Publication date
RU2369634C2 (ru)	2009-10-10
MA27631A1 (fr)	2005-11-01
WO2004078955A1 (en)	2004-09-16
BRPI0407636A (pt)	2006-02-21
CO5601047A2 (es)	2006-01-31
MXPA05009096A (es)	2005-10-19
GB0304799D0 (en)	2003-04-09
EP1599580A1 (en)	2005-11-30
EP2192175A1 (en)	2010-06-02
JP2006519023A (ja)	2006-08-24
JP4787739B2 (ja)	2011-10-05
KR101242090B1 (ko)	2013-03-08
CA2517327A1 (en)	2004-09-16
CN1756837B (zh)	2010-05-26
AU2004217807A1 (en)	2004-09-16
NO20054124L (no)	2005-09-27
JP2010273683A (ja)	2010-12-09
NZ541908A (en)	2008-04-30
KR20050105509A (ko)	2005-11-04
NO20054124D0 (no)	2005-09-05
US20060183224A1 (en)	2006-08-17
US8034617B2 (en)	2011-10-11
CN1756837A (zh)	2006-04-05
RU2005125606A (ru)	2006-03-10
EP2186885A1 (en)	2010-05-19
AU2004217807B2 (en)	2009-06-25
CN101200705A (zh)	2008-06-18

Publication	Publication Date	Title
IS7992A (is)	2005-08-18	Dýralaus frumuræktunar aðferð
IL173165A0 (en)	2006-06-11	Cell cultivation and breeding method
DK1897548T4 (da)	2024-08-26	T-celleregulering
DE602004010273D1 (de)	2008-01-03	Amplifikationsmethode
DE602004022088D1 (de)	2009-08-27	Zellkultivierungskolben
DE602004026708D1 (de)	2010-06-02	Brennstoffzellensystem
GB2404665B (en)	2005-07-06	Cell culture
EP1765986A4 (en)	2007-11-07	CELL PRESERVATION PROCESS
DE602004025608D1 (de)	2010-04-01	Brennstoffzelle
DE602004030501D1 (de)	2011-01-27	Brennstoffzelle
DE502004008433D1 (de)	2008-12-18	Wägezelle
NO20035626D0 (no)	2003-12-17	Metode
ZA200506732B (en)	2007-02-28	Cell culture
NO20035401D0 (no)	2003-12-04	Metode
DE60304815D1 (de)	2006-06-01	Zellkulturverfahren
FI20050870A7 (fi)	2007-03-02	Parannettu fermentointimenetelmä hiivageenejä korjaamalla
DE60336113D1 (de)	2011-04-07	Aufzeichnungsverfahren
WO2006027835A1 (ja)	2006-03-16	ゲノム解析方法
GB0315262D0 (en)	2003-08-06	Methods of cell culture
FI20035152A0 (fi)	2003-09-11	Häiritsevän solun etsintä menetelmä
GB0319804D0 (en)	2003-09-24	Cell culture method
FI20031356L (fi)	2004-09-17	Menetelmä ja järjestely polttokennoja varten
SE0302280D0 (sv)	2003-08-22	Cells
SE0402853D0 (sv)	2004-11-23	Method for culturing mammalian cells
DE60219082D1 (de)	2007-05-03	Poröses gefäss-enthaltender bioreaktor